HEOR
Unleashing the Value of Innovative Healthcare Technologies
Conquering the Unimaginable
We're motivated by the urgency to generate robust and differentiated value for innovative healthcare technologies entering the market. As a leading value science company, Syenza offers integrated HEOR services that create credible value for our clients. Our unparalleled scientific, strategic, and operational capacity magnify the value of our clients' assets in the Pharma, Medtech, and Biotech industries.
Value Communications
Syenza develops agile,
tech-enabled Global Value
Dossiers and localized HTA
submissions to set in motion
the value of innovative
healthcare technologies. Our
GVDs and HTA submissions
strengthen the interlinkages
between the clinical,
economic and humanistic
outcomes to facilitate
decision-making.
Health Economic Analyses
Syenza reveals the
differentiated value of
innovations by determining
the comprehensive health
economic impact of healthcare
technologies. Our interactive
cost-effectiveness and
budget impact models are
validated before they
inform decision-making on
the value and affordability
of innovations.
Scientific Writing
Syenza is more than just
medical writers; we are
Scientific Partners for your
Business. Our innovative,
fit-for-purpose publication
strategies deliver high-quality
evidence synthesis for early
value communication, payor
engagement, critical
assessment of clinical and
economic outcomes, horizon
scanning, and targeted
evidence reviews.
Service Outcomes
Clients receive actionable insights in Cost-Effectiveness and Budget Impact Technical Reports with a complete Dynamic Model.
Clients deploy our insights to guide the development of GVDs and submissions to HTA agencies.
Clients integrate publishable systematic literature reviews, burden of illness studies, manuscripts, abstracts, and posters.
View Our Recent Articles
NICE HealthTech Methods Update
🤔 How can we ensure that health technology truly delivers value? The latest **NICE HealthTech Methods Update** provides vital insights into refining how we evaluate health technologies, focusing on stakeholder...
Global Health Technology Assessment: Navigating NICE’s...
🌍 Are we truly ready to adapt global health technology assessments to local realities? The latest article from NICE explores how their evidence-based health policy initiatives are shaping access and value...
Revolutionizing Pharmacoeconomic Evaluations Nederland:...
🌍 How can we enhance transparency in pharmacoeconomic evaluations? The Dutch National Health Care Institute is introducing a transformative framework for pharmacoeconomic evaluations that emphasizes clarity,...
